Deflazacort vs prednisone treatment for Duchenne muscular dystrophy
Deflazacort vs prednisone treatment for Duchenne muscular dystrophy: A meta‐analysis of disease progression rates in recent multicenter clinical trials
Craig M. McDonald, MD, Gautam Sajeev, ScD, Zhiwen Yao, BA, Erin McDonnell, MS, Gary Elfring, MS, Marcio Souza, PharmD, MBA, Stuart W. Peltz, PhD, Basil T. Darras, MD, Perry B. Shieh, MD, PhD, David A. Cox, PhD, John Landry, MMath, James Signorovitch, PhD, and for the ACT DMD Study Group and the Tadalafil DMD Study Group. Muscle Nerve. 2020 Jan; 61(1): 26–35.